These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21339722)

  • 1. An orthotopic model of murine bladder cancer.
    Dobek GL; Godbey WT
    J Vis Exp; 2011 Feb; (48):. PubMed ID: 21339722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urothelial susceptibility to tumor cell implantation: influence of cauterization.
    Soloway MS; Masters S
    Cancer; 1980 Sep; 46(5):1158-63. PubMed ID: 7214299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental model of Walker 256 carcinosarcoma in rats bladder].
    Dornelas CA; Almeida PR; Nascimento GL; Lima EB; Moraes MO
    Acta Cir Bras; 2006; 21(1):38-42. PubMed ID: 16491221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Establishment and application of an orthotopic murine bladder cancer model].
    Yang SM; Wen DG; Hou JQ; He J; Cen JN; Chen JH
    Ai Zheng; 2007 Apr; 26(4):341-5. PubMed ID: 17430648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An orthotopic bladder tumor model and the evaluation of intravesical saRNA treatment.
    Kang MR; Yang G; Charisse K; Epstein-Barash H; Manoharan M; Li LC
    J Vis Exp; 2012 Jul; (65):. PubMed ID: 22872227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment.
    Huebner D; Rieger C; Bergmann R; Ullrich M; Meister S; Toma M; Wiedemuth R; Temme A; Novotny V; Wirth MP; Bachmann M; Pietzsch J; Fuessel S
    BMC Cancer; 2017 Nov; 17(1):790. PubMed ID: 29169339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder cancer and squamous metaplasia in spinal cord injury patients.
    Kaufman JM; Fam B; Jacobs SC; Gabilondo F; Yalla S; Kane JP; Rossier AB
    J Urol; 1977 Dec; 118(6):967-71. PubMed ID: 926277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A simple and efficient method for establishing a mouse model of orthotopic MB49 bladder cancer].
    Liang ZK; Zhang L; Hu ZM; Chen Z; Huang X; Shi XH; Tan WL; Gao JM
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):627-30. PubMed ID: 19403380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor establishment features of orthotopic murine bladder cancer models.
    Lee JS; Bae MH; Choi SH; Lee SH; Cho YS; Park HJ; Kwon CH; Joo KJ
    Korean J Urol; 2012 Jun; 53(6):396-400. PubMed ID: 22741047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunostimulatory CpG oligonucleotides reduce tumor burden after intravesical administration in an orthotopic murine bladder cancer model.
    Hegele A; Dalpke A; Heeg K; Barth P; Varga Z; Hofmann R; Olbert P
    Tumour Biol; 2005; 26(5):274-80. PubMed ID: 16103747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of prostate specific antigen to measure bladder tumor growth in a mouse orthotopic model.
    Luo Y; Chen X; O'donnell MA
    J Urol; 2004 Dec; 172(6 Pt 1):2414-20. PubMed ID: 15538283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Murine Orthotopic Bladder Tumor Model and Tumor Detection System.
    Tham SM; Esuvaranathan K; Mahendran R
    J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive detection of bladder cancer in an orthotopic murine model with green fluorescence protein cytology.
    Tanaka M; Gee JR; De La Cerda J; Rosser CJ; Zhou JH; Benedict WF; Grossman HB
    J Urol; 2003 Sep; 170(3):975-8. PubMed ID: 12913753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing orthotopic bladder tumor implantation in a syngeneic mouse model.
    Chan ES; Patel AR; Smith AK; Klein JB; Thomas AA; Heston WD; Larchian WA
    J Urol; 2009 Dec; 182(6):2926-31. PubMed ID: 19846165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-viral tumor necrosis factor-alpha gene transfer decreases the incidence of orthotopic bladder tumors.
    Zang Z; Mahendran R; Wu Q; Yong T; Esuvaranathan K
    Int J Mol Med; 2004 Oct; 14(4):713-7. PubMed ID: 15375606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological characterization of a syngeneic orthotopic murine bladder cancer model.
    Chade DC; Andrade PM; Borra RC; Leite KR; Andrade E; Villanova FE; Srougi M
    Int Braz J Urol; 2008; 34(2):220-6; discussion 226-9. PubMed ID: 18462521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioluminescence imaging to monitor bladder cancer cell adhesion in vivo: a new approach to optimize a syngeneic, orthotopic, murine bladder cancer model.
    Jurczok A; Fornara P; Söling A
    BJU Int; 2008 Jan; 101(1):120-4. PubMed ID: 17888045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of implantation of murine bladder tumor by thiotepa in cauterized bladder.
    Pan JS; Slocum HK; Rustum YM; Greco WR; Gaeta JF; Huben RP
    J Urol; 1989 Dec; 142(6):1589-93. PubMed ID: 2511340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of chronic catheterization in the development of bladder cancer in patients with spinal cord injury.
    West DA; Cummings JM; Longo WE; Virgo KS; Johnson FE; Parra RO
    Urology; 1999 Feb; 53(2):292-7. PubMed ID: 9933042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonviral cytokine gene therapy on an orthotopic bladder cancer model.
    Wu Q; Mahendran R; Esuvaranathan K
    Clin Cancer Res; 2003 Oct; 9(12):4522-8. PubMed ID: 14555526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.